Novel bacteria gene activation method developed
Researchers have created a new technique for activating genes using bacteria which could have therapeutic uses.
List view / Grid view
Researchers have created a new technique for activating genes using bacteria which could have therapeutic uses.
A tumour-targeted CRISPR gene editing system encapsulated in a nanogel could halt the growth of triple-negative breast cancer.
Modern cell biology requires a wide variety of applications to keep up with the numerous exciting directions that research takes us. Detection technologies ranging from fluorescence to cellular imaging have become common in today’s laboratories.
Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.
A research team have used genome editing to correct two of the mutations that cause cystic fibrosis.
Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.
Salk scientists discover a pair of enzymes that drive non-small-cell lung cancer by promoting inflammation which could inform the development of new therapies.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Researchers used screening to discover genes that protect the body against the Zika virus, which could inform potential therapies against the virus.
A study has used new synthetic lipids to deliver CRISPR gene editing tools into cells with up to 90 percent efficiency.
A research team have developed a new CRISPR platform called RESCUE (RNA Editing for Specific C to U Exchange).
Researchers have generated images of CRISPR-Cas9 gene editing for the first time, enabling improvement of the technique.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
Researchers have analysed the physical origin and biological consequences of DNA-RNA hybrids which could inform gene therapies.
The patent office has declared an interference between 10 University of California (UC) patent applications.